ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea
· Delayed Price · Currency is KRW 73,700
+100 (0.14%)
May 14, 2025, 11:40 AM KST
ST Pharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 34,712 | 19,581 | 18,000 | 3,312 | -12,147 | Upgrade
|
| Depreciation & Amortization | 25,582 | 23,027 | 17,600 | 14,414 | 14,068 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1,692 | 0.62 | 515.43 | 2,543 | 10.89 | Upgrade
|
| Asset Writedown & Restructuring Costs | -47.79 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -12,390 | 8,063 | 628.83 | -147.24 | -3,258 | Upgrade
|
| Stock-Based Compensation | 3,246 | 5,298 | 5,019 | 2,116 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 3.87 | 188.27 | -0.06 | -138.94 | 13.84 | Upgrade
|
| Other Operating Activities | 19,948 | 9,920 | 6,088 | 6,619 | 1,160 | Upgrade
|
| Change in Accounts Receivable | 53,012 | -25,749 | -47,568 | -6,471 | -6,696 | Upgrade
|
| Change in Inventory | -12,944 | -13,226 | -25,939 | -37,301 | -8,173 | Upgrade
|
| Change in Accounts Payable | -7,321 | -369.93 | 6,071 | 8,169 | -2,455 | Upgrade
|
| Change in Other Net Operating Assets | 3,958 | -25,435 | 26,615 | 14,154 | -3,458 | Upgrade
|
| Operating Cash Flow | 109,451 | 1,298 | 7,031 | 7,270 | -20,935 | Upgrade
|
| Operating Cash Flow Growth | 8329.82% | -81.53% | -3.29% | - | - | Upgrade
|
| Capital Expenditures | -82,806 | -43,244 | -60,479 | -51,792 | -16,989 | Upgrade
|
| Sale of Property, Plant & Equipment | 168.5 | 100.94 | 3.67 | 612.72 | 145.53 | Upgrade
|
| Sale (Purchase) of Intangibles | -238.11 | -198.7 | 108.52 | -125.09 | -455.24 | Upgrade
|
| Investment in Securities | -8,021 | -40,708 | 54,085 | 42,492 | -51,351 | Upgrade
|
| Other Investing Activities | 4,354 | 1,662 | 557.09 | 779.23 | -424.75 | Upgrade
|
| Investing Cash Flow | -86,543 | -82,388 | -5,724 | -8,034 | -69,074 | Upgrade
|
| Short-Term Debt Issued | 25,000 | 25,878 | 20,000 | - | - | Upgrade
|
| Long-Term Debt Issued | 190.16 | 101,454 | 16,500 | - | 118,500 | Upgrade
|
| Total Debt Issued | 25,190 | 127,332 | 36,500 | - | 118,500 | Upgrade
|
| Short-Term Debt Repaid | -24,211 | -33,333 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -1,679 | -1,861 | -16,750 | -1,019 | -1,087 | Upgrade
|
| Total Debt Repaid | -25,890 | -35,195 | -16,750 | -1,019 | -1,087 | Upgrade
|
| Net Debt Issued (Repaid) | -699.68 | 92,137 | 19,750 | -1,019 | 117,413 | Upgrade
|
| Dividends Paid | -9,404 | -9,404 | -9,404 | - | - | Upgrade
|
| Other Financing Activities | -849.82 | -1,331 | 462.3 | 903.14 | -1,486 | Upgrade
|
| Financing Cash Flow | -10,954 | 81,401 | 10,808 | -115.59 | 115,927 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1,353 | -415.46 | -1,117 | 1,457 | -115.29 | Upgrade
|
| Net Cash Flow | 13,308 | -103.91 | 10,998 | 578.18 | 25,802 | Upgrade
|
| Free Cash Flow | 26,646 | -41,946 | -53,448 | -44,522 | -37,924 | Upgrade
|
| Free Cash Flow Margin | 9.73% | -14.72% | -21.44% | -26.88% | -30.56% | Upgrade
|
| Free Cash Flow Per Share | 1366.16 | -2230.12 | -2841.64 | -2385.36 | -2032.81 | Upgrade
|
| Cash Interest Paid | 817.46 | 1,331 | 929.58 | 447.67 | 435.11 | Upgrade
|
| Cash Income Tax Paid | 4,955 | 2,118 | 2,868 | -826.64 | 10.89 | Upgrade
|
| Levered Free Cash Flow | 10,548 | -58,932 | -68,609 | -73,918 | -29,471 | Upgrade
|
| Unlevered Free Cash Flow | 15,384 | -55,116 | -66,817 | -70,695 | -29,068 | Upgrade
|
| Change in Net Working Capital | -55,538 | 55,645 | 35,204 | 36,677 | 13,931 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.